Normal hematopoiesis is a tightly regulated process involving a balance bet
ween signals that stimulate and those that inhibit the proliferation and di
fferentiation of hematopoietic progenitors. In chronic myeloid leukemia (CM
L) there is a perturbation of these controlling elements, resulting in over
growth of leukemic cells in the bone marrow and spleen. In part, the prolif
eration of CML CD34+ cells may result from an abnormal response to the cyto
kine Stem Cell Factor (SCF). SCF induced proliferation and adhesion to the
extracellular matrix via fibronectin are not coupled in CML as they are in
normal cells and this may contribute to the accumulation of leukemic progen
itors. We have previously shown that CD34+ CML cells and the more primitive
CD34+CD38- CML cells do not require the addition of synergistic cytokines
to cultures, but are capable of proliferation in SCF alone, and that leukem
ic CFU-GM are selectively supported in these cultures. In the presence of o
ther cytokines the response of CML cells to SCF is no greater than that of
cells from normal donors, suggesting that the leukemic cells are not more s
ensitive to SCE but that accessory pathways are already activated in these
cells. Cells from patients with myeloproliferative disorders show variable
proliferative response to SCF as the sole mitogenic stimulus, suggesting th
at expression of bcr-abl is essential for proliferation in this cytokine. F
urther studies to identify the key determinants of the abnormal response to
SCF in CML may lead to a better understanding of the proliferative abnorma
lity that underlies CML.